Interact to see
Advertisement
Advertisement
CEBRX vs MEDEX
CEBRX vs MEDEX Comparison
Open Charts CEBRX vs MEDEX
Columbia Emerging Markets Bond Inst2
Price$9.99
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets341.82M
MFS Emerging Markets Debt R2
Price$12.58
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets7.55B
CEBRX vs MEDEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CEBRX vs. MEDEX commentary
Oct 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEBRX is a Hold and MEDEX is a Hold.
FUNDAMENTALS
Fundamentals
MEDEX has more cash in the bank: 7.55B vs. CEBRX (342M). CEBRX (5.27) and MEDEX (5.02) have matching dividends . CEBRX was incepted earlier than MEDEX: CEBRX (13 years) vs MEDEX (17 years). MEDEX (1.32) is less costly to investors than CEBRX (0.75). MEDEX is a more actively managed with annual turnover of: 58.00 vs. CEBRX (41.00). CEBRX (0) and MEDEX (0) have matching initial minimum investment requirements. CEBRX annual gain was more profitable for investors over the last year : 8.42 vs. MEDEX (7.28). CEBRX return over 5 years is better than : 13.23 vs. MEDEX (10.98).
| CEBRX | MEDEX | CEBRX / MEDEX | |
| Total Expense Ratio | 0.75 | 1.31 | 57% |
| Annual Report Gross Expense Ratio | 0.75 | 1.32 | 57% |
| Fund Existence | 13 years | 17 years | - |
| Gain YTD | 9.871 | 8.773 | 113% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 342M | 7.55B | 5% |
| Annual Yield % from dividends | 5.27 | 5.02 | 105% |
| Returns for 1 year | 8.42 | 7.28 | 116% |
| Returns for 3 years | 39.62 | 37.92 | 104% |
| Returns for 5 years | 13.23 | 10.98 | 120% |
| Returns for 10 years | 50.14 | 41.76 | 120% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement